Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (AB-CliniMACs)

    ... receiving alternative donor (unrelated or partially matched related) mobilized peripheral stem cells (PSCs) using the CliniMACS ...

    Clinical Trial last updated 06/03/2016 - 2:45pm.

  2. HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy (RAFA)

    ... of cyclosporine will further reduce transplant-related side effects for patients with Fanconi Anemia (FA). Patients will undergo a transplant utilizing mis-matched related or matched unrelated donors following a preparative regimen of ...

    Clinical Trial last updated 05/09/2016 - 3:19pm.

  3. Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

    ... following a T-cell depleted stem cell graft from a related haploidentical donor. All patients are planned to receive two ATIR101 doses of 2×10E6 viable ... Availability of a fully matched related or unrelated donor following a donor search ...

    Clinical Trial last updated 04/29/2016 - 12:25pm.

  4. Busulfan and Cyclophosphamide Followed By ALLO BMT

    ... Acceptable stem cell sources include: HLA -matched related or unrelated donor bone marrow (6/6 or 5/6 antigen match) ...

    Clinical Trial last updated 04/29/2016 - 1:23pm.

  5. New York Blood Center National Cord Blood Program

    ... myeloid and platelet engraftment , transplant related mortality, overall survival, graft vs. host disease and, for patients ... Cord Blood Transplantation Other Name: One or more matched umbilical cord blood units for transplant ...

    Clinical Trial last updated 06/13/2016 - 1:43pm.

  6. GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant

    ... must have a healthy HLA compatible (8/8 molecularly matched related, or unrelated) donor willing to undergo BM harvesting or PBSC apheresis ...

    Clinical Trial last updated 04/29/2016 - 12:40pm.

  7. StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies

    ... Must have a partially HLA matched UCB unit with a pre-cryopreserved TNC dose >2.5 x 107 per kilogram ... (e.g, second partially HLA matched UCB unit, haploidentical related donor). Voluntary written consent signed (adult or parental) before ...

    Clinical Trial last updated 06/03/2016 - 2:37pm.

  8. Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

    ... or, Myelodysplastic Syndrome (MDS): Primary or therapy related; or, Acute Lymphoblastic Leukemia (ALL): induction failure, primary ... Patients must have two CB units available which are matched with the patient at 4, 5, or 6/6 HLA class I (serological) and ...

    Clinical Trial last updated 06/06/2016 - 12:58pm.

  9. Personalized Natural Killer (NK) Cell Therapy in Cord Blood Transplantation (CBT)

    ... Myelodysplastic Syndrome (MDS): Primary or therapy related, including patients that will be considered for transplant. These ... Availability of appropriate, willing, HLA -matched related stem cell donor. Intervention:  ...

    Clinical Trial last updated 06/06/2016 - 10:28am.

  10. Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies

    ... cord blood selection can prioritize matching and better matched donors can be identified rapidly for most subjects. ... An human leukocyte antigen ( HLA )-identical related or unrelated donor cannot be identified within an appropriate ...

    Clinical Trial last updated 04/29/2016 - 1:15pm.